Goa, India

Rao Gollapudi

This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rao Gollapudi. Retrieved from https://idiyas.com/inventor/rao-gollapudi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rao Gollapudi: Innovator in Therapeutic Applications of Withanolides

Introduction

Rao Gollapudi is a distinguished inventor based in Goa, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on withanolides. His research focuses on developing novel compounds for the treatment of various diseases.

Latest Patents

Rao Gollapudi holds 1 patent that features novel withanolides, as well as analogs and salts thereof. This patent is aimed at addressing proliferative diseases, cardiovascular diseases, neurodegenerative diseases, and inflammatory diseases. His work represents a significant advancement in therapeutic options for these conditions.

Career Highlights

Gollapudi is affiliated with the University of Kansas, where he continues to engage in groundbreaking research. His academic background and expertise have positioned him as a key figure in the study of withanolides and their potential applications in medicine.

Collaborations

Some of his notable coworkers include Barbara N. Timmermann and Mark S. Cohen. Their collaborative efforts have further enhanced the research and development of therapeutic agents derived from withanolides.

Conclusion

Rao Gollapudi's innovative work in the field of medicinal chemistry highlights the potential of withanolides in treating serious health conditions. His contributions are paving the way for new therapeutic strategies that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…